Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

The PCV13 vaccine makes it easier for the immune system to attack S. pneumoniae and produce antibodies by linking the polysaccharide capsule layer to proteins. Exposure to neonatal antibiotics ...

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

Results from a retrospective case-control study indicate that the pneumococcal vaccine provides significant protection in all HIV-infected patients, not just those with CD4 counts ≥200 cells/mm 3.